Federation des caisses Desjardins du Quebec’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2 Hold
1
﹤0.01% 2959
2025
Q4
$2 Sell
1
-1,400
-100% -$3.32K ﹤0.01% 2874
2025
Q3
$4.27K Buy
1,401
+1,400
+140,000% +$4.37K ﹤0.01% 2494
2025
Q2
$3 Hold
1
﹤0.01% 2713
2025
Q1
$2 Buy
+1
New +$2 ﹤0.01% 2651
2020
Q1
Sell
-4
Closed -$41 2304
2019
Q4
$41 Hold
4
﹤0.01% 2288
2019
Q3
$21 Hold
4
﹤0.01% 2261
2019
Q2
$21 Hold
4
﹤0.01% 2244
2019
Q1
$31 Hold
4
﹤0.01% 2061
2018
Q4
$7 Hold
4
﹤0.01% 2066
2018
Q3
$30 Hold
4
﹤0.01% 2121
2018
Q2
$41 Hold
4
﹤0.01% 2140
2018
Q1
$37 Hold
4
﹤0.01% 2138
2017
Q4
$56 Hold
4
﹤0.01% 2120
2017
Q3
$64 Hold
4
﹤0.01% 2069
2017
Q2
$78 Buy
+4
New +$221 ﹤0.01% 2132

Other funds holding MBOT

Federation des caisses Desjardins du Quebec's MBOT Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Microbot Medical (MBOT) position steady in Q1 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #2959.

Federation des caisses Desjardins du Quebec first reported a position in MBOT in Q2 2017 and has held it in 16 quarters since. The position peaked at $4.27K in Q3 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 1 share of Microbot Medical worth $2 as of Q1 2026.
  • Federation des caisses Desjardins du Quebec left its Microbot Medical share count unchanged in Q1 2026.
  • Microbot Medical made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2959 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Microbot Medical in Q2 2017 and has held it in 16 quarters since.
  • Federation des caisses Desjardins du Quebec's Microbot Medical position peaked at $4.27K in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.